Lupus

>

Latest News

Low-Dose CAR-T Shows Efficacy in Pediatric Systemic Lupus Erythematosus
Low-Dose CAR-T Shows Efficacy in Pediatric Systemic Lupus Erythematosus

October 29th 2024

Four of 5 participants with follow-up reaching 3 months have achieved SRI-4 disease responses.

Mithu Maheswaranathan, MD | Credit: Duke Health
Understanding Ultra-Processed Food Intake and Risk of Lupus

October 13th 2024

Fiona du Monceau, Head of Patient Evidence at UCB
Dapirolizumab Pegol Meets Primary Endpoint in Phase 3 Study for SLE

September 25th 2024

Mithunan Maheswaranathan, MD, assistant professor of medicine, rheumatology and immunology, rheumatology fellowship, Duke University School of Medicine
Black Women With Limited Health Literacy Identified as Vulnerable to Systemic Lupus Erythematosus Impact

August 29th 2024

Danielle Rasooly, PhD, Centers for Disease Control and Prevention, Atlanta, Georgia
Family History of Arthritis Increases Risk for Multiple Rheumatological Conditions

August 21st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.